Garretson, SD, August 25, 2014 --(PR.com
)-- Braasch Biotech's President and CSO, Dr. Keith Haffer, has been invited to host a Seminar at Informa's 9th Annual Veterinary Vaccine Meeting in Brussels, Belgium (December 3-4). The seminar is entitled "Matching Adjuvants to Product Profile and Desired Outcomes."
This interactive evening seminar will provide participants with an in-depth understanding of the latest development in adjuvants, and how to match adjuvants with veterinary vaccines products. Dr. Haffer will be talking to participants about his personal adjuvant journey over the last 34 years, with specific adjuvant case studies, and the application of a decision matrix to help choose adjuvants. The latter will allow participants supplied examples to be addressed and discussed during the seminar.
Dr. Haffer continues his work in veterinary vaccine adjuvants at both Braasch Biotech and also an independent consultant for Advantage Bio Consultants, Inc. Dr. Haffer is the inventor of numerous adjuvants, most recently for use in Braasch's anti-somatostatin vaccines for livestock and pets.